CPH Chemie + Papier Holding AG, together with its subsidiaries, develops, manufactures and distributes chemical products, paper, and pharmaceutical packaging films in Switzerland, rest of Europe, the Americas, Asia, and internationally.
Flawless balance sheet with proven track record.
Share Price & News
How has CPH Chemie + Papier Holding's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CPHN has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: CPHN underperformed the Swiss Forestry industry which returned 2.9% over the past year.
Return vs Market: CPHN underperformed the Swiss Market which returned -0.5% over the past year.
Price Volatility Vs. Market
How volatile is CPH Chemie + Papier Holding's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall StHere's Why CPH Chemie + Papier Holding (VTX:CPHN) Can Manage Its Debt Responsibly
2 weeks ago | Simply Wall StWith EPS Growth And More, CPH Chemie + Papier Holding (VTX:CPHN) Is Interesting
1 month ago | Simply Wall StIs CPH Chemie + Papier Holding AG's (VTX:CPHN) Latest Stock Performance A Reflection Of Its Financial Health?
Is CPH Chemie + Papier Holding undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: CPHN (CHF67.6) is trading above our estimate of fair value (CHF67.06)
Significantly Below Fair Value: CPHN is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CPHN is good value based on its PE Ratio (8.4x) compared to the Forestry industry average (10.8x).
PE vs Market: CPHN is good value based on its PE Ratio (8.4x) compared to the Swiss market (19.3x).
Price to Earnings Growth Ratio
PEG Ratio: CPHN's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: CPHN is good value based on its PB Ratio (0.9x) compared to the XE Forestry industry average (1x).
How is CPH Chemie + Papier Holding forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CPHN's earnings are forecast to decline over the next 3 years (-10.9% per year).
Earnings vs Market: CPHN's earnings are forecast to decline over the next 3 years (-10.9% per year).
High Growth Earnings: CPHN's earnings are forecast to decline over the next 3 years.
Revenue vs Market: CPHN's revenue (0.1% per year) is forecast to grow slower than the Swiss market (2.4% per year).
High Growth Revenue: CPHN's revenue (0.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CPHN's Return on Equity is forecast to be low in 3 years time (6.5%).
How has CPH Chemie + Papier Holding performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CPHN has high quality earnings.
Growing Profit Margin: CPHN's current net profit margins (9.2%) are higher than last year (7.9%).
Past Earnings Growth Analysis
Earnings Trend: CPHN has become profitable over the past 5 years, growing earnings by 64.3% per year.
Accelerating Growth: CPHN's earnings growth over the past year (14.3%) is below its 5-year average (64.3% per year).
Earnings vs Industry: CPHN earnings growth over the past year (14.3%) exceeded the Forestry industry -1.5%.
Return on Equity
High ROE: CPHN's Return on Equity (11%) is considered low.
How is CPH Chemie + Papier Holding's financial position?
Financial Position Analysis
Short Term Liabilities: CPHN's short term assets (CHF266.6M) exceed its short term liabilities (CHF95.9M).
Long Term Liabilities: CPHN's short term assets (CHF266.6M) exceed its long term liabilities (CHF165.5M).
Debt to Equity History and Analysis
Debt Level: CPHN's debt to equity ratio (27.7%) is considered satisfactory.
Reducing Debt: CPHN's debt to equity ratio has reduced from 34.1% to 27.7% over the past 5 years.
Debt Coverage: CPHN's debt is well covered by operating cash flow (49.9%).
Interest Coverage: CPHN's interest payments on its debt are well covered by EBIT (12.3x coverage).
What is CPH Chemie + Papier Holding current dividend yield, its reliability and sustainability?
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CPHN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CPHN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CPHN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CPHN's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: CPHN is not paying a notable dividend for the Swiss market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CPHN's dividend in 3 years as they are not forecast to pay a notable one for the Swiss market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Peter Schildknecht (58yo)
Dr. Peter Schildknecht has been Group Chief Executive Officer of CPH Chemie + Papier Holding AG since January 1, 2009. Mr. Schildknecht's professional career in industry began in 1995 at Von Roll, where he ...
CEO Compensation Analysis
Compensation vs Market: Peter's total compensation ($USD1.01M) is about average for companies of similar size in the Swiss market ($USD1.01M).
Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.
|Group Chief Executive Officer||11.5yrs||CHF955.00k||0.0033% CHF13.5k|
|Chief Financial Officer||4.5yrs||no data||0.0042% CHF16.9k|
|Head of Packaging Division||17.5yrs||no data||0.0010% CHF4.1k|
|Head of the Chemistry Division||10.5yrs||no data||0.0067% CHF27.1k|
|Head of Paper Division||8.5yrs||no data||no data|
Experienced Management: CPHN's management team is seasoned and experienced (10.5 years average tenure).
|Deputy Chairman||4.67yrs||CHF105.00k||0.87% CHF3.5m|
Experienced Board: CPHN's board of directors are considered experienced (7.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
CPH Chemie + Papier Holding AG's company bio, employee growth, exchange listings and data sources
- Name: CPH Chemie + Papier Holding AG
- Ticker: CPHN
- Exchange: SWX
- Founded: 1818
- Industry: Paper Products
- Sector: Materials
- Market Cap: CHF405.561m
- Shares outstanding: 6.00m
- Website: https://www.cph.ch
Number of Employees
- CPH Chemie + Papier Holding AG
- Perlenring 1
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CPHN||SWX (SIX Swiss Exchange)||Yes||Registered Shares||CH||CHF||Jun 2001|
|0QNZ||LSE (London Stock Exchange)||Yes||Registered Shares||GB||CHF||Jun 2001|
CPH Chemie + Papier Holding AG, together with its subsidiaries, develops, manufactures and distributes chemical products, paper, and pharmaceutical packaging films in Switzerland, rest of Europe, the Americas, Asia, and internationally. It operates through three divisions: Chemistry, Paper, and Packaging. The Chemistry division provides molecular sieves for industrial applications; chromatography gels for the pharmaceuticals industry; and deuterated solvents for laboratory analysis use. This division offers its products under the Zeochem brand name. The Paper division produces newsprint and magazine paper products under the Perlen Papier brand. The Packaging division provides a range of PVC monofilms and coated PVdC barrier films under the Perlen Packaging brand name for use in the pharmaceuticals industry. The company was founded in 1818 and is based in Root, Switzerland.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/07/01 20:56|
|End of Day Share Price||2020/07/01 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.